カテゴリー： Market Monitor Global, 世界, 医療/バイオ

注射用スマトリプタンの世界市場見通し2023年-2029年

◆英語タイトル：Injectable Sumatriptan Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8812 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：75 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Injectable Sumatriptan Market 調査レポートは次の情報を含め、グローバルにおけるの注射用スマトリプタン市場規模と予測を収録しています。・世界の注射用スマトリプタン市場：売上、2018年-2023年、2024年-2029年
・世界の注射用スマトリプタン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の注射用スマトリプタン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「4mg」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

注射用スマトリプタンのグローバル主要企業は、GlaxoSmithKline、 Pfizer、 Teva、 Sun Pharmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、注射用スマトリプタンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の注射用スマトリプタン市場：タイプ別、2018年-2023年、2024年-2029年
世界の注射用スマトリプタン市場：タイプ別市場シェア、2022年
・4mg、6mg、その他

世界の注射用スマトリプタン市場：用途別、2018年-2023年、2024年-2029年
世界の注射用スマトリプタン市場：用途別市場シェア、2022年
・病院、クリニック、その他

世界の注射用スマトリプタン市場：地域・国別、2018年-2023年、2024年-2029年
世界の注射用スマトリプタン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における注射用スマトリプタンのグローバル売上、2018年-2023年
・主要企業における注射用スマトリプタンのグローバル売上シェア、2022年
・主要企業における注射用スマトリプタンのグローバル販売量、2018年-2023年
・主要企業における注射用スマトリプタンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
GlaxoSmithKline、 Pfizer、 Teva、 Sun Pharma

*************************************************************

・調査・分析レポートの概要
注射用スマトリプタン市場の定義
市場セグメント
世界の注射用スマトリプタン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の注射用スマトリプタン市場規模
世界の注射用スマトリプタン市場規模：2022年 VS 2029年
世界の注射用スマトリプタン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの注射用スマトリプタンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の注射用スマトリプタン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：4mg、6mg、その他
注射用スマトリプタンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、クリニック、その他
注射用スマトリプタンの用途別グローバル売上・予測

・地域別市場分析
地域別注射用スマトリプタン市場規模 2022年と2029年
地域別注射用スマトリプタン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
GlaxoSmithKline、 Pfizer、 Teva、 Sun Pharma
...

Sumatriptan injection comes as a solution (liquid) to inject subcutaneously (just under your skin). It is usually used at the first sign of a migraine headache. If your symptoms improve after you use sumatriptan but return after 1 hour or longer, you may use a second dose of sumatriptan.
This report aims to provide a comprehensive presentation of the global market for Injectable Sumatriptan, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Sumatriptan. This report contains market size and forecasts of Injectable Sumatriptan in global, including the following market information:
Global Injectable Sumatriptan Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Injectable Sumatriptan Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Injectable Sumatriptan companies in 2022 (%)
The global Injectable Sumatriptan market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
4mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Injectable Sumatriptan include GlaxoSmithKline, Pfizer, Teva and Sun Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Injectable Sumatriptan manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injectable Sumatriptan Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Injectable Sumatriptan Market Segment Percentages, by Type, 2022 (%)
4mg
6mg
Others
Global Injectable Sumatriptan Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Injectable Sumatriptan Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Injectable Sumatriptan Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Injectable Sumatriptan Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Injectable Sumatriptan revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Injectable Sumatriptan revenues share in global market, 2022 (%)
Key companies Injectable Sumatriptan sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Injectable Sumatriptan sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Pfizer
Teva
Sun Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Injectable Sumatriptan, market overview.
Chapter 2: Global Injectable Sumatriptan market size in revenue and volume.
Chapter 3: Detailed analysis of Injectable Sumatriptan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Injectable Sumatriptan in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Injectable Sumatriptan capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Injectable Sumatriptan Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Injectable Sumatriptan Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Injectable Sumatriptan Overall Market Size
2.1 Global Injectable Sumatriptan Market Size: 2022 VS 2029
2.2 Global Injectable Sumatriptan Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Injectable Sumatriptan Sales: 2018-2029
3 Company Landscape
3.1 Top Injectable Sumatriptan Players in Global Market
3.2 Top Global Injectable Sumatriptan Companies Ranked by Revenue
3.3 Global Injectable Sumatriptan Revenue by Companies
3.4 Global Injectable Sumatriptan Sales by Companies
3.5 Global Injectable Sumatriptan Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Injectable Sumatriptan Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Injectable Sumatriptan Product Type
3.8 Tier 1, Tier 2 and Tier 3 Injectable Sumatriptan Players in Global Market
3.8.1 List of Global Tier 1 Injectable Sumatriptan Companies
3.8.2 List of Global Tier 2 and Tier 3 Injectable Sumatriptan Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Injectable Sumatriptan Market Size Markets, 2022 & 2029
4.1.2 4mg
4.1.3 6mg
4.1.4 Others
4.2 By Type – Global Injectable Sumatriptan Revenue & Forecasts
4.2.1 By Type – Global Injectable Sumatriptan Revenue, 2018-2023
4.2.2 By Type – Global Injectable Sumatriptan Revenue, 2024-2029
4.2.3 By Type – Global Injectable Sumatriptan Revenue Market Share, 2018-2029
4.3 By Type – Global Injectable Sumatriptan Sales & Forecasts
4.3.1 By Type – Global Injectable Sumatriptan Sales, 2018-2023
4.3.2 By Type – Global Injectable Sumatriptan Sales, 2024-2029
4.3.3 By Type – Global Injectable Sumatriptan Sales Market Share, 2018-2029
4.4 By Type – Global Injectable Sumatriptan Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Injectable Sumatriptan Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global Injectable Sumatriptan Revenue & Forecasts
5.2.1 By Application – Global Injectable Sumatriptan Revenue, 2018-2023
5.2.2 By Application – Global Injectable Sumatriptan Revenue, 2024-2029
5.2.3 By Application – Global Injectable Sumatriptan Revenue Market Share, 2018-2029
5.3 By Application – Global Injectable Sumatriptan Sales & Forecasts
5.3.1 By Application – Global Injectable Sumatriptan Sales, 2018-2023
5.3.2 By Application – Global Injectable Sumatriptan Sales, 2024-2029
5.3.3 By Application – Global Injectable Sumatriptan Sales Market Share, 2018-2029
5.4 By Application – Global Injectable Sumatriptan Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Injectable Sumatriptan Market Size, 2022 & 2029
6.2 By Region – Global Injectable Sumatriptan Revenue & Forecasts
6.2.1 By Region – Global Injectable Sumatriptan Revenue, 2018-2023
6.2.2 By Region – Global Injectable Sumatriptan Revenue, 2024-2029
6.2.3 By Region – Global Injectable Sumatriptan Revenue Market Share, 2018-2029
6.3 By Region – Global Injectable Sumatriptan Sales & Forecasts
6.3.1 By Region – Global Injectable Sumatriptan Sales, 2018-2023
6.3.2 By Region – Global Injectable Sumatriptan Sales, 2024-2029
6.3.3 By Region – Global Injectable Sumatriptan Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Injectable Sumatriptan Revenue, 2018-2029
6.4.2 By Country – North America Injectable Sumatriptan Sales, 2018-2029
6.4.3 US Injectable Sumatriptan Market Size, 2018-2029
6.4.4 Canada Injectable Sumatriptan Market Size, 2018-2029
6.4.5 Mexico Injectable Sumatriptan Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Injectable Sumatriptan Revenue, 2018-2029
6.5.2 By Country – Europe Injectable Sumatriptan Sales, 2018-2029
6.5.3 Germany Injectable Sumatriptan Market Size, 2018-2029
6.5.4 France Injectable Sumatriptan Market Size, 2018-2029
6.5.5 U.K. Injectable Sumatriptan Market Size, 2018-2029
6.5.6 Italy Injectable Sumatriptan Market Size, 2018-2029
6.5.7 Russia Injectable Sumatriptan Market Size, 2018-2029
6.5.8 Nordic Countries Injectable Sumatriptan Market Size, 2018-2029
6.5.9 Benelux Injectable Sumatriptan Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Injectable Sumatriptan Revenue, 2018-2029
6.6.2 By Region – Asia Injectable Sumatriptan Sales, 2018-2029
6.6.3 China Injectable Sumatriptan Market Size, 2018-2029
6.6.4 Japan Injectable Sumatriptan Market Size, 2018-2029
6.6.5 South Korea Injectable Sumatriptan Market Size, 2018-2029
6.6.6 Southeast Asia Injectable Sumatriptan Market Size, 2018-2029
6.6.7 India Injectable Sumatriptan Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Injectable Sumatriptan Revenue, 2018-2029
6.7.2 By Country – South America Injectable Sumatriptan Sales, 2018-2029
6.7.3 Brazil Injectable Sumatriptan Market Size, 2018-2029
6.7.4 Argentina Injectable Sumatriptan Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Injectable Sumatriptan Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Injectable Sumatriptan Sales, 2018-2029
6.8.3 Turkey Injectable Sumatriptan Market Size, 2018-2029
6.8.4 Israel Injectable Sumatriptan Market Size, 2018-2029
6.8.5 Saudi Arabia Injectable Sumatriptan Market Size, 2018-2029
6.8.6 UAE Injectable Sumatriptan Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Injectable Sumatriptan Major Product Offerings
7.1.4 GlaxoSmithKline Injectable Sumatriptan Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Injectable Sumatriptan Major Product Offerings
7.2.4 Pfizer Injectable Sumatriptan Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Teva
7.3.1 Teva Company Summary
7.3.2 Teva Business Overview
7.3.3 Teva Injectable Sumatriptan Major Product Offerings
7.3.4 Teva Injectable Sumatriptan Sales and Revenue in Global (2018-2023)
7.3.5 Teva Key News & Latest Developments
7.4 Sun Pharma
7.4.1 Sun Pharma Company Summary
7.4.2 Sun Pharma Business Overview
7.4.3 Sun Pharma Injectable Sumatriptan Major Product Offerings
7.4.4 Sun Pharma Injectable Sumatriptan Sales and Revenue in Global (2018-2023)
7.4.5 Sun Pharma Key News & Latest Developments
8 Global Injectable Sumatriptan Production Capacity, Analysis
8.1 Global Injectable Sumatriptan Production Capacity, 2018-2029
8.2 Injectable Sumatriptan Production Capacity of Key Manufacturers in Global Market
8.3 Global Injectable Sumatriptan Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Injectable Sumatriptan Supply Chain Analysis
10.1 Injectable Sumatriptan Industry Value Chain
10.2 Injectable Sumatriptan Upstream Market
10.3 Injectable Sumatriptan Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Injectable Sumatriptan Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Injectable Sumatriptan in Global Market
Table 2. Top Injectable Sumatriptan Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Injectable Sumatriptan Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Injectable Sumatriptan Revenue Share by Companies, 2018-2023
Table 5. Global Injectable Sumatriptan Sales by Companies, (K Units), 2018-2023
Table 6. Global Injectable Sumatriptan Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Injectable Sumatriptan Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Injectable Sumatriptan Product Type
Table 9. List of Global Tier 1 Injectable Sumatriptan Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Injectable Sumatriptan Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Injectable Sumatriptan Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Injectable Sumatriptan Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Injectable Sumatriptan Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Injectable Sumatriptan Sales (K Units), 2018-2023
Table 15. By Type - Global Injectable Sumatriptan Sales (K Units), 2024-2029
Table 16. By Application – Global Injectable Sumatriptan Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Injectable Sumatriptan Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Injectable Sumatriptan Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Injectable Sumatriptan Sales (K Units), 2018-2023
Table 20. By Application - Global Injectable Sumatriptan Sales (K Units), 2024-2029
Table 21. By Region – Global Injectable Sumatriptan Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Injectable Sumatriptan Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Injectable Sumatriptan Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Injectable Sumatriptan Sales (K Units), 2018-2023
Table 25. By Region - Global Injectable Sumatriptan Sales (K Units), 2024-2029
Table 26. By Country - North America Injectable Sumatriptan Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Injectable Sumatriptan Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Injectable Sumatriptan Sales, (K Units), 2018-2023
Table 29. By Country - North America Injectable Sumatriptan Sales, (K Units), 2024-2029
Table 30. By Country - Europe Injectable Sumatriptan Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Injectable Sumatriptan Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Injectable Sumatriptan Sales, (K Units), 2018-2023
Table 33. By Country - Europe Injectable Sumatriptan Sales, (K Units), 2024-2029
Table 34. By Region - Asia Injectable Sumatriptan Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Injectable Sumatriptan Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Injectable Sumatriptan Sales, (K Units), 2018-2023
Table 37. By Region - Asia Injectable Sumatriptan Sales, (K Units), 2024-2029
Table 38. By Country - South America Injectable Sumatriptan Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Injectable Sumatriptan Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Injectable Sumatriptan Sales, (K Units), 2018-2023
Table 41. By Country - South America Injectable Sumatriptan Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Injectable Sumatriptan Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Injectable Sumatriptan Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Injectable Sumatriptan Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Injectable Sumatriptan Sales, (K Units), 2024-2029
Table 46. GlaxoSmithKline Company Summary
Table 47. GlaxoSmithKline Injectable Sumatriptan Product Offerings
Table 48. GlaxoSmithKline Injectable Sumatriptan Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. GlaxoSmithKline Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Injectable Sumatriptan Product Offerings
Table 52. Pfizer Injectable Sumatriptan Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Teva Company Summary
Table 55. Teva Injectable Sumatriptan Product Offerings
Table 56. Teva Injectable Sumatriptan Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Teva Key News & Latest Developments
Table 58. Sun Pharma Company Summary
Table 59. Sun Pharma Injectable Sumatriptan Product Offerings
Table 60. Sun Pharma Injectable Sumatriptan Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Sun Pharma Key News & Latest Developments
Table 62. Injectable Sumatriptan Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 63. Global Injectable Sumatriptan Capacity Market Share of Key Manufacturers, 2021-2023
Table 64. Global Injectable Sumatriptan Production by Region, 2018-2023 (K Units)
Table 65. Global Injectable Sumatriptan Production by Region, 2024-2029 (K Units)
Table 66. Injectable Sumatriptan Market Opportunities & Trends in Global Market
Table 67. Injectable Sumatriptan Market Drivers in Global Market
Table 68. Injectable Sumatriptan Market Restraints in Global Market
Table 69. Injectable Sumatriptan Raw Materials
Table 70. Injectable Sumatriptan Raw Materials Suppliers in Global Market
Table 71. Typical Injectable Sumatriptan Downstream
Table 72. Injectable Sumatriptan Downstream Clients in Global Market
Table 73. Injectable Sumatriptan Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Injectable Sumatriptan Segment by Type in 2022
Figure 2. Injectable Sumatriptan Segment by Application in 2022
Figure 3. Global Injectable Sumatriptan Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Injectable Sumatriptan Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Injectable Sumatriptan Revenue, 2018-2029 (US$, Mn)
Figure 7. Injectable Sumatriptan Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Injectable Sumatriptan Revenue in 2022
Figure 9. By Type - Global Injectable Sumatriptan Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Injectable Sumatriptan Revenue Market Share, 2018-2029
Figure 11. By Type - Global Injectable Sumatriptan Sales Market Share, 2018-2029
Figure 12. By Type - Global Injectable Sumatriptan Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Injectable Sumatriptan Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Injectable Sumatriptan Revenue Market Share, 2018-2029
Figure 15. By Application - Global Injectable Sumatriptan Sales Market Share, 2018-2029
Figure 16. By Application - Global Injectable Sumatriptan Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Injectable Sumatriptan Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Injectable Sumatriptan Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Injectable Sumatriptan Revenue Market Share, 2018-2029
Figure 20. By Region - Global Injectable Sumatriptan Sales Market Share, 2018-2029
Figure 21. By Country - North America Injectable Sumatriptan Revenue Market Share, 2018-2029
Figure 22. By Country - North America Injectable Sumatriptan Sales Market Share, 2018-2029
Figure 23. US Injectable Sumatriptan Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Injectable Sumatriptan Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Injectable Sumatriptan Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Injectable Sumatriptan Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Injectable Sumatriptan Sales Market Share, 2018-2029
Figure 28. Germany Injectable Sumatriptan Revenue, (US$, Mn), 2018-2029
Figure 29. France Injectable Sumatriptan Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Injectable Sumatriptan Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Injectable Sumatriptan Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Injectable Sumatriptan Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Injectable Sumatriptan Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Injectable Sumatriptan Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Injectable Sumatriptan Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Injectable Sumatriptan Sales Market Share, 2018-2029
Figure 37. China Injectable Sumatriptan Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Injectable Sumatriptan Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Injectable Sumatriptan Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Injectable Sumatriptan Revenue, (US$, Mn), 2018-2029
Figure 41. India Injectable Sumatriptan Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Injectable Sumatriptan Revenue Market Share, 2018-2029
Figure 43. By Country - South America Injectable Sumatriptan Sales Market Share, 2018-2029
Figure 44. Brazil Injectable Sumatriptan Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Injectable Sumatriptan Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Injectable Sumatriptan Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Injectable Sumatriptan Sales Market Share, 2018-2029
Figure 48. Turkey Injectable Sumatriptan Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Injectable Sumatriptan Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Injectable Sumatriptan Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Injectable Sumatriptan Revenue, (US$, Mn), 2018-2029
Figure 52. Global Injectable Sumatriptan Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Injectable Sumatriptan by Region, 2022 VS 2029
Figure 54. Injectable Sumatriptan Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 注射用スマトリプタンの世界市場見通し2023年-2029年(Injectable Sumatriptan Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

注射用スマトリプタンの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp